Cell-Free DNA Isolation And Extraction Market Size, Share, Trends, Growth Rate And Forecast To 2033

The new report published by The Business Research Company, titled Cell-Free DNA Isolation And Extraction Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the cell-free DNA isolation and extraction market size has grown strongly in recent years. It will grow from $1.81 billion in 2023 to $1.93 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The cell-free DNA isolation and extraction market size is expected to see strong growth in the next few years. It will grow to $2.49 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%.

Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16371&type=smp

Impact Of Cancer Prevalence On The Cell-Free DNA Isolation And Extraction Market
The rising prevalence of cancer is expected to propel the growth of the cell-free DNA isolation and extraction market going forward. Cancer is a complex group of diseases characterized by the uncontrolled growth and spread of abnormal cells, often forming tumors, with the potential to invade other parts of the body, impair normal bodily functions, and, if left untreated, result in severe illness or death. Cancer cases are increasing due to the obesity epidemic, inherited genetic abnormalities, hepatitis B and C viruses, Epstein-Barr virus (EBV), and human papillomavirus (HPV). Cell-free DNA (cfDNA) extraction and isolation techniques enable comprehensive genomic analysis of cancer, offering valuable insights into tumor biology, treatment response, and disease progression. These techniques potentially revolutionize cancer management by facilitating early detection, personalized treatment approaches, and improved patient outcomes. For instance, in May 2024, according to the American Society of Clinical Oncology, a US-based professional organization, approximately 20 million new cases of cancer were diagnosed in 2022, which is estimated to reach 35 million by 2050, resulting in an estimated 9.7 million deaths attributed to the disease. Therefore, the rising prevalence of cancer is driving the growth of the cell-free DNA isolation and extraction market.

Role Of Personalized Medicine In Expanding The Cell-Free DNA Isolation And Extraction Market

The growing demand for personalized medicine is expected to propel the growth of the cell-free DNA isolation and extraction market going forward. Personalized medicine is a medical approach that customizes healthcare decisions and treatments for individual patients based on their genetic makeup, environmental factors, and lifestyle. The growing demand for personalized medicines is driven by higher rates of cancer and the increasing incidence of chronic diseases among the population. Cell-free DNA isolation and extraction in personalized medicine offer a non-invasive and comprehensive approach to diagnosing, monitoring, and treating diseases, particularly cancer, based on an individual's unique genetic makeup. For instance, in 2022, according to the Personalized Medicine Coalition, a US-based professional membership organization, 12 new customized medications were approved in 2022, accounting for around 34% of all newly approved treatments, a significant increase over prior years. Therefore, the growing demand for personalized medicine is driving the growth of the cell-free DNA isolation and extraction market.

Innovative Products Driving Competition In The Cell-Free DNA Isolation And Extraction Market
Major companies operating in the cell-free DNA isolation and extraction market are focusing on developing innovative products, such as automated DNA extraction instruments, to gain a competitive edge in the market. Automated DNA extraction instruments are sophisticated laboratory devices designed to streamline and automate the process of isolating DNA from various biological samples. For instance, in September 2023, Yourgene Health plc, a UK-based molecular diagnostics company, launched the MagBench Automated DNA Extraction Instrument and Kit to optimize its Sage 32 NIPT workflow in Asia-Pacific and the Middle East. This innovative solution offers several unique features designed to streamline and enhance the DNA extraction process for prenatal screening. The MagBench instrument combines automation with precision, utilizing magnetic bead-based technology to efficiently isolate high-quality DNA from maternal blood samples.

The cell-free DNA isolation and extraction market covered in this report is segmented -

1) By Product Type: Kits, Reagents, Instruments
2) By Technology: Column-Based Isolation And Extraction, Magnetic Beads, Silica Membranes
3) By Application: Non-Invasive Prenatal Testing (NIPT), Oncology, Transplant Rejection, Other Applications
4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Biotech And Pharma Companies

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16371&type=discount

Major companies operating in the cell-free DNA isolation and extraction market are F. Hoffmann-La Roche AG, Merck KGaA, Novartis AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Natera Inc., Promega Corporation, STRATEC Biomedical AG, STRECK Inc., Omega Bio-tek Inc., SeraCare Life Sciences Inc., Yourgene Health plc, System Biosciences LLC, PreAnalytiX GmbH, Bioo Scientific Corporation, BioCAT GmbH, Norgen Biotek Corp., Epigentek Group Inc., NVIGEN Inc.

Contents of the report:
1. Executive Summary
2. Cell-Free DNA Isolation And Extraction Market Report Structure
3. Cell-Free DNA Isolation And Extraction Market Trends And Strategies
4. Cell-Free DNA Isolation And Extraction Market - Macro Economic Scenario
5. Cell-Free DNA Isolation And Extraction Market Size And Growth
…..
27. Cell-Free DNA Isolation And Extraction Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/cell-free-dna-isolation-and-extraction-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.